We’re experts in breast cancer screening and what makes someone high risk. High risk people are cared for differently. If you’re considered high risk for breast cancer, we’ll watch you for early signs ...

Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. Over the next 12 months, tens of thousands of women across ...

Using artificial intelligence (AI) in breast cancer screenings in the United Kingdom could be cost-effective and improve health outcomes after identifying more cancers. Integrating risk-stratified ...

Phase II Trial of nab-Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update Family history (FH) and pathogenic variants (PVs ...

Adjunct Associate Professor, The Daffodil Centre, a joint venture between the University of Sydney and Cancer Council NSW, and Associate Professor, Melbourne School of Population and Global Health, ...